A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.
Autoantibodies that bind to the thyroid-stimulating hormone (TSH) receptor (RECEPTORS, THYROTROPIN) on thyroid epithelial cells. The autoantibodies mimic TSH causing an unregulated production of thyroid hormones characteristic of GRAVES DISEASE.
A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.
Cell surface proteins that bind pituitary THYROTROPIN (also named thyroid stimulating hormone or TSH) and trigger intracellular changes of the target cells. TSH receptors are present in the nervous system and on target cells in the thyroid gland. Autoantibodies to TSH receptors are implicated in thyroid diseases such as GRAVES DISEASE and Hashimoto disease (THYROIDITIS, AUTOIMMUNE).
A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively.
Inflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis.
A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534)
An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
An imidazole antithyroid agent. Carbimazole is metabolized to METHIMAZOLE, which is responsible for the antithyroid activity.
A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
Chronic autoimmune thyroiditis, characterized by the presence of high serum thyroid AUTOANTIBODIES; GOITER; and HYPOTHYROIDISM.
Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.
Spontaneously remitting inflammatory condition of the THYROID GLAND, characterized by FEVER; MUSCLE WEAKNESS; SORE THROAT; severe thyroid PAIN; and an enlarged damaged gland containing GIANT CELLS. The disease frequently follows a viral infection.
The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.
Inflammatory diseases of the THYROID GLAND. Thyroiditis can be classified into acute (THYROIDITIS, SUPPURATIVE), subacute (granulomatous and lymphocytic), chronic fibrous (Riedel's), chronic lymphocytic (HASHIMOTO DISEASE), transient (POSTPARTUM THYROIDITIS), and other AUTOIMMUNE THYROIDITIS subtypes.
A glycoprotein hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Thyrotropin stimulates THYROID GLAND by increasing the iodide transport, synthesis and release of thyroid hormones (THYROXINE and TRIIODOTHYRONINE). Thyrotropin consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the pituitary glycoprotein hormones (TSH; LUTEINIZING HORMONE and FSH), but the beta subunit is unique and confers its biological specificity.
Blood tests used to evaluate the functioning of the thyroid gland.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE.
Surgical removal of the thyroid gland. (Dorland, 28th ed)
Pathological processes involving the THYROID GLAND.
An enlarged THYROID GLAND containing multiple nodules (THYROID NODULE), usually resulting from recurrent thyroid HYPERPLASIA and involution over many years to produce the irregular enlargement. Multinodular goiters may be nontoxic or may induce THYROTOXICOSIS.
Thyroglobulin is a glycoprotein synthesized and secreted by thyroid follicular cells, serving as a precursor for the production of thyroid hormones T3 and T4, and its measurement in blood serves as a tumor marker for thyroid cancer surveillance.
A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC).
Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes.
Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.
A hemeprotein that catalyzes the oxidation of the iodide radical to iodine with the subsequent iodination of many organic compounds, particularly proteins. EC 1.11.1.8.
A dangerous life-threatening hypermetabolic condition characterized by high FEVER and dysfunction of the cardiovascular, the nervous, and the gastrointestinal systems.
A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA.
Bony cavity that holds the eyeball and its associated tissues and appendages.
An immunoglobulin G, often found in the blood of hyperthyroid individuals. It stimulates the thyroid for a longer duration than does thyrotoxin and may cause hyperthyroidism in newborns due to placental transmission.
Tumors or cancer of the THYROID GLAND.
A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints.
Stealing of corpses after burial, especially for medical dissection. In the late 18th and early 19th centuries, in the absence of laws governing the acquisition of dissecting material for the study of anatomy, the needs of anatomy classes were met by surreptitious methods: body-snatching and grave robbing. (Random House Unabridged Dictionary, 2d ed; from Garrison, An Introduction to the History of Medicine, 4th ed, p447; from Castiglioni, A History of Medicine, 2d ed, p676)
Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
Diseases affecting the eye.
The muscles that move the eye. Included in this group are the medial rectus, lateral rectus, superior rectus, inferior rectus, inferior oblique, superior oblique, musculus orbitalis, and levator palpebrae superioris.
Defective development of the THYROID GLAND. This concept includes thyroid agenesis (aplasia), hypoplasia, or an ectopic gland. Clinical signs usually are those of CONGENITAL HYPOTHYROIDISM.
Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)

Postoperative tetany in Graves disease: important role of vitamin D metabolites. (1/1222)

OBJECTIVE: To test the authors' hypothesis of the causal mechanism(s) of postoperative tetany in patients with Graves disease. SUMMARY BACKGROUND DATA: Previous studies by the authors suggested that postoperative tetany in patients with Graves disease occurs during the period of bone restoration and resulted from continuation of a calcium flux into bone concomitant with transient hypoparathyroidism induced by surgery. PATIENTS AND METHODS: A prospective study was carried out to investigate sequential changes in serum levels of intact parathyroid hormone (iPTH), calcium and other electrolytes, 25-hydroxyvitamin D (25OHD), 1,25-dihydroxyvitamin D (1,25(OH)2D), and bone metabolic markers in 109 consecutive patients with Graves disease who underwent subtotal thyroidectomy. RESULTS: Preoperative serum iPTH levels negatively correlated with ionized calcium levels and positively correlated with 1,25(OH)2D or 1,25(OH)2D/25OHD. After the operation, there was a significant decline in levels of ionized calcium, magnesium, and iPTH. Serum iPTH was not detected in 15 patients after surgery. Four of these 15 patients, and 1 patient whose iPTH level was below normal, developed tetany. Preoperative serum ionized calcium levels were significantly lower, and iPTH levels were higher, in the 5 patients with tetany than in the 11 patients who did not develop tetany despite undetectable iPTH levels. The tetany group had significantly lower serum 25OHD levels and higher 1,25(OH)2D levels, and had increased 1,25(OH)2D/25OHD as an index of the renal 25OHD-1-hydroxylase activity than those in the nontetany group. These results suggest that patients with a high serum level of iPTH as a result of low serum calcium levels (secondary hyperparathyroidism) are susceptible to tetany under conditions of hypoparathyroid function after surgery. CONCLUSIONS: Postoperative tetany occurs in patients with secondary hyperparathyroidism caused by a relative deficiency in calcium and vitamin D because of their increased demand for bone restoration after preoperative medical therapy concomitant with transient hypoparathyroidism after surgery. Calcium and vitamin D supplements may be recommended before and/or after surgery for patients in whom postoperative tetany is expected to develop.  (+info)

HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules. (2/1222)

Thyroid follicular cells (TFC) in Graves' disease (GD) hyperexpress HLA class I and express ectopic HLA class II molecules, probably as a consequence of cytokines produced by infiltrating T cells. This finding led us to postulate that TFC could act as antigen-presenting cells, and in this way be responsible for the induction and/or maintenance of the in situ autoimmune T cell response. Invariant chain (li) and HLA-DM molecules are implicated in the antigen processing and presentation by HLA class II molecules. We have investigated the expression of these molecules by TFC from GD glands. The results demonstrate that class II+ TFC from GD patients also express li and HLA-DM, and this expression is increased after IFN-gamma stimulation. The level of HLA-DM expression by TFC was low but sufficient to catalyze peptide loading into the HLA class II molecules and form stable HLA class II-peptide complexes expressed at the surface of TFC. These results have implications for the understanding of the possible role of HLA class II+ TFC in thyroid autoimmune disease.  (+info)

A single technique to correct various degrees of upper lid retraction in patients with Graves' orbitopathy. (3/1222)

BACKGROUND: Several lengthening techniques have been proposed for upper eyelid retraction in patients with Graves' orbitopathy and variable rates of success have been reported. Most authors recommend different procedures for different degrees of retraction, but cannot prevent residual temporal retraction in a significant number of cases. The modified levator aponeurosis recession described by Harvey and colleagues, in which the lateral horn is cut completely, seems to be an exception to this rule, but was evaluated in a limited number of cases only. METHOD: The authors further modified Harvey's technique by dissecting the aponeurosis together with Muller's muscle of the tarsus and the conjunctiva medially only to the extent necessary to achieve an acceptable position and contour of the eyelid in upright position. They also used an Ethilon 6.0 suture, instead of Vicryl, on a loop. It is placed between the tarsal plate and the detached aponeurosis to prevent spontaneous disinsertion. This modification was used in 50 Graves' patients (78 eyelids) with a upper lid margin-limbus distance ranging from 1 to 7 mm and evaluated using strict criteria. RESULTS: A perfect or acceptable result was obtained in 23 of 28 patients (82%) with bilateral retraction and in 18 of 22 patients (82%) with unilateral retraction. Seven eyelids were overcorrected (too low) and three undercorrected, necessitating reoperation. All other eyelids had an almond-like contour and a lid crease of 10 mm or less. No complications except subcutaneous haematomas were seen. Two patients showed a recurrence of lid retraction 9 months after the operation. CONCLUSION: This technique is safe and efficacious and can be used for all degrees of eyelid retraction.  (+info)

Significance of serum antibodies reactive with flavoprotein subunit of succinate dehydrogenase in thyroid associated orbitopathy. (4/1222)

AIMS: Thyroid associated orbitopathy (TAO) is an autoimmune disorder of extraocular muscles and orbital connective tissue. Identification of the principal target antigens would help the understanding of the pathogenesis of the disease and possibly lead to the development of specific therapies in the future. The purpose of this study was to measure serum antibodies against the flavoprotein subunit of succinate dehydrogenase in patients with TAO and correlate their presence with factors of TAO. METHODS: Sera of patients with active TAO of 6 months' duration or less were tested for antibodies against the flavoprotein subunit of succinate dehydrogenase. Clinical data were obtained by retrospective review of patients' charts. Enzyme linked immunosorbent assay was used to test sera for serum antibodies against purified succinate dehydrogenase. RESULTS: 38 patients with TAO and 32 healthy age and sex matched controls were included in the study. Anti-flavoprotein antibodies were detected in 24 out of 38 patients with TAO (63.16%) and in five out of 32 healthy controls (15.63%) (p<0.01). Neither age, sex, duration of thyroid disease, thyroid status, treatment of thyroid disease, smoking history, duration of orbitopathy, activity of orbitopathy, nor the presence of lid retraction were significantly associated with the presence of serum anti-flavoprotein antibodies (p>0.05). However, the total number of rectus muscles affected in both eyes of the patients was significantly correlated with the finding of a positive antibody test (p<0.05). CONCLUSIONS: Serum antibodies reactive with the flavoprotein subunit of succinate dehydrogenase are associated with extraocular muscle involvement in active TAO of recent onset.  (+info)

The role of octreoscan in thyroid eye disease. (5/1222)

Until recently there was no imaging technique available which could demonstrate pathological changes in orbital tissues and could be regarded as a reliable measure of inflammation in thyroid eye disease (TED). Pentetreotide (a synthetic derivative of somatostatin) labelled with 111In has been used to localize tumours which possess surface or membrane receptors for somatostatin in vivo using a gamma camera (1). This technique visualizes somatostatin receptors in endocrine-related tumours in vivo and predicts the inhibitory effect of the somatostatin analogue octreotide on hormone secretion by the tumours (1). By applying 111In-DTPA-d-Phe octreotide scintigraphy (octreoscan), accumulation of the radionuclide was also detected in both the thyroid and orbit of patients with Graves' disease (2-4). If peak activity in the orbit 5h after injection of radiolabelled octreotide is set at 100%, a decrease to 40+/-4% is found at 24h, significantly different from the decrease in blood pool radioactivity, which is 15+/-4% at 24h. Accumulation of the radionuclide is most probably due to the presence in the orbital tissue of activated lymphocytes bearing somatostatin receptors (5). Alternative explanations are binding to receptors on other cell types (e.g. myoblasts, fibroblasts or endothelial cells) or local blood pooling due to venous stasis by the autoimmune orbital inflammation.  (+info)

The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. (6/1222)

Graves' disease (GD) is an autoimmune thyroid disorder that is inherited as a complex trait. We have genotyped 77 affected sib-pairs with autoimmune thyroid disease for eight polymorphic markers spanning the cytotoxic T lymphocyte antigen-4 ( CTLA-4 ) region of chromosome 2q31-q33, and for five markers spanning the major histocompatibility complex ( MHC ) region of chromosome 6p21. Non-parametric analysis showed linkage of GD to the CTLA-4 region with a peak non-parametric linkage (NPL) score of 3.43 ( P = 0.0004) at the marker D2S117. The proportion of affected full-sibs sharing zero alleles (z0) reached a minimum of 0.113 close to D2S117, giving a locus-specific lambdas for this region of 2.2. Families with brother-sister sib-pairs showed a peak NPL of 3.46 ( P = 0.0003, lambdas > 10) at D2S117, compared with 2.00 ( P = 0.02, lambdas = 1.9) in the families with only affected females, suggesting a stronger influence in families with affected males. Association between GD and the G allele of the Thr17Ala polymorphism within the CTLA-4 gene ( CTLA4A/G ) was observed using unaffected sib controls ( P = 0.005). Lesser evidence for linkage was found at the MHC locus, with a peak NPL score of 1.95 ( P = 0.026), between the markers D6S273 and TNFalpha. We demonstrate that the CTLA-4 locus (lambdas = 2.2) and the MHC locus (lambdas = 1.6) together confer approximately 50% of the inherited susceptibility to GD disease in our population.  (+info)

Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' disease. (7/1222)

Autoimmune diseases which follow allogeneic BMT from a donor who is a patient or a carrier of an autoimmune condition are considered to be a paradigm of adoptive autoimmunity. Seven cases of autoimmune thyroiditis associated with clinical hyperthyroidism have been published to date. In the case reported here a 35-year-old female patient with AML of the M2 subtype received unmanipulated PBSC from her HLA-identical sister who had therapeutically controlled Graves' disease. Antithyroid antibodies, including thyrotropin receptor (TSHR) antibodies, appeared 1 year after transplant. Clinical hyperthyroidism requiring thyrostatic medication appeared after 2 years. The biological and clinical implications of adoptive, post-transplant autoimmunity are briefly discussed.  (+info)

The effect of thyrotropin receptor antibodies on the proliferation of FRTL-5 cells and the expression of protooncogene c-fos mRNA. (8/1222)

OBJECTIVE: Hyperthyroidism and a diffuse goiter are the main symptoms of Graves' disease (GD) associated with autoantibodies to thyroid-stimulating hormone (TSH) receptor (TRAb). The present study was conducted to evaluate effects of autoantibodies in patients with GD (TRAb-IgG) on induction of the proliferation and c-fos mRNA expression in FRTL-5 cells (Fisher rat thyroid cell line). METHODS: Highly purified IgG fractions were isolated from 11 patients with GD, TRAb-IgG and 15 normal individuals (normal controls) with Protein A Sepharose CL-4B affinity column chromatograph. FRTL-5 cells, which had been grown to subconfluency and deprived of TSH for a few days. Then, these cells were used for measuring cAMP content, 3H-thymidine incorporation in cells and the expression of c-fos mRNA respectively. RESULTS: After stimulation of TRAb-IgG, the cAMP production and 3H-thymidine incorporation in FRTL-5 cells were much higher than those from normal controls (P < 0.05 respectively). Using 32P labelled v-fos probe by the Northern Blot method, the expression of c-fos mRNA could be induced by IgGs from patients with GD. CONCLUSIONS: These data suggest that the stimulation of TRAb-IgG followed by cAMP production and 3H-thymidine incorporation is related to the induction of c-fos mRNA and, thus, to the growth of FRTL-5 cells.  (+info)

Graves' disease is defined as an autoimmune disorder that leads to overactivity of the thyroid gland (hyperthyroidism). It results when the immune system produces antibodies that stimulate the thyroid gland, causing it to produce too much thyroid hormone. This can result in a variety of symptoms such as rapid heartbeat, weight loss, heat intolerance, and bulging eyes (Graves' ophthalmopathy). The exact cause of Graves' disease is unknown, but it is more common in women and people with a family history of the disorder. Treatment may include medications to control hyperthyroidism, radioactive iodine therapy to destroy thyroid tissue, or surgery to remove the thyroid gland.

Antithyroid agents are a class of medications that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by inhibiting the production of thyroid hormones in the thyroid gland. There are several types of antithyroid agents available, including:

1. Propylthiouracil (PTU): This medication works by blocking the enzyme that is needed to produce thyroid hormones. It also reduces the conversion of thyroxine (T4) to triiodothyronine (T3), another thyroid hormone, in peripheral tissues.
2. Methimazole: This medication works similarly to propylthiouracil by blocking the enzyme that is needed to produce thyroid hormones. However, it does not affect the conversion of T4 to T3 in peripheral tissues.
3. Carbimazole: This medication is converted to methimazole in the body and works similarly to block the production of thyroid hormones.

Antithyroid agents are usually taken orally, and their effects on thyroid hormone production begin within a few hours after ingestion. However, it may take several weeks for patients to notice an improvement in their symptoms. These medications can have side effects, including rash, hives, and joint pain. In rare cases, they can cause liver damage or agranulocytosis, a condition in which the body does not produce enough white blood cells.

It is important to note that antithyroid agents do not cure hyperthyroidism; they only treat the symptoms by reducing thyroid hormone production. Therefore, patients may need to take these medications for several months or even years, depending on their individual circumstances. In some cases, surgery or radioactive iodine therapy may be recommended as alternative treatments for hyperthyroidism.

Immunoglobulins, Thyroid-Stimulating (TSI), are autoantibodies that bind to the thyroid-stimulating hormone receptor (TSHR) on the surface of thyroid cells. These antibodies mimic the action of TSH and stimulate the growth and function of the thyroid gland, leading to excessive production of thyroid hormones. This results in a condition known as Graves' disease, which is characterized by hyperthyroidism, goiter, and sometimes ophthalmopathy (eye problems). The presence and titer of TSIs are used in the diagnosis of Graves' disease.

Methimazole is an anti-thyroid medication that is primarily used to treat hyperthyroidism, a condition in which the thyroid gland produces excessive amounts of thyroid hormones. It works by inhibiting the enzyme thyroperoxidase, which is essential for the production of thyroid hormones. By blocking this enzyme, methimazole reduces the amount of thyroid hormones produced by the thyroid gland, helping to restore normal thyroid function.

Methimazole is available in oral tablet form and is typically taken two to three times a day. Common side effects of methimazole include nausea, vomiting, skin rashes, and joint pain. In rare cases, it can cause more serious side effects such as liver damage or agranulocytosis (a severe decrease in white blood cell count).

It is important to note that methimazole should only be used under the close supervision of a healthcare provider, as regular monitoring of thyroid function and potential side effects is necessary. Additionally, it may take several weeks or months of treatment with methimazole before thyroid function returns to normal.

Thyrotropin receptors (TSHRs) are a type of G protein-coupled receptor found on the surface of cells in the thyroid gland. They bind to thyroid-stimulating hormone (TSH), which is produced and released by the pituitary gland. When TSH binds to the TSHR, it activates a series of intracellular signaling pathways that stimulate the production and release of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). These hormones are important for regulating metabolism, growth, and development in the body. Mutations in the TSHR gene can lead to various thyroid disorders, such as hyperthyroidism or hypothyroidism.

The thyroid gland is a major endocrine gland located in the neck, anterior to the trachea and extends from the lower third of the Adams apple to the suprasternal notch. It has two lateral lobes, connected by an isthmus, and sometimes a pyramidal lobe. This gland plays a crucial role in the metabolism, growth, and development of the human body through the production of thyroid hormones (triiodothyronine/T3 and thyroxine/T4) and calcitonin. The thyroid hormones regulate body temperature, heart rate, and the production of protein, while calcitonin helps in controlling calcium levels in the blood. The function of the thyroid gland is controlled by the hypothalamus and pituitary gland through the thyroid-stimulating hormone (TSH).

Autoimmune thyroiditis, also known as Hashimoto's disease, is a chronic inflammation of the thyroid gland caused by an autoimmune response. In this condition, the immune system produces antibodies that attack and damage the thyroid gland, leading to hypothyroidism (underactive thyroid). The thyroid gland may become enlarged (goiter), and symptoms can include fatigue, weight gain, cold intolerance, constipation, dry skin, and depression. Autoimmune thyroiditis is more common in women than men and tends to run in families. It is often associated with other autoimmune disorders such as rheumatoid arthritis, Addison's disease, and type 1 diabetes. The diagnosis is typically made through blood tests that measure levels of thyroid hormones and antibodies. Treatment usually involves thyroid hormone replacement therapy to manage the symptoms of hypothyroidism.

Propylthiouracil is a medication that is primarily used to treat hyperthyroidism, a condition characterized by an overactive thyroid gland that produces too much thyroid hormone. The medication works by inhibiting the production of thyroid hormones in the body. It belongs to a class of drugs called antithyroid agents or thionamides.

In medical terms, propylthiouracil is defined as an antithyroid medication used to manage hyperthyroidism due to Graves' disease or toxic adenoma. It acts by inhibiting the synthesis of thyroid hormones, triiodothyronine (T3) and thyroxine (T4), in the thyroid gland. Propylthiouracil also reduces the peripheral conversion of T4 to T3. The medication is available as a tablet for oral administration and is typically prescribed at a starting dose of 100-150 mg three times daily, with adjustments made based on the patient's response and thyroid function tests.

It's important to note that propylthiouracil should be used under the close supervision of a healthcare provider due to potential side effects and risks associated with its use. Regular monitoring of thyroid function tests is necessary during treatment, and patients should promptly report any signs or symptoms of adverse reactions to their healthcare provider.

Graves' ophthalmopathy, also known as Graves' eye disease or thyroid eye disease, is an autoimmune condition that affects the eyes. It often occurs in individuals with Graves' disease, an autoimmune disorder that causes hyperthyroidism (overactive thyroid gland). However, it can also occur in people without Graves' disease.

In Graves' ophthalmopathy, the immune system attacks the tissue behind the eyes, causing inflammation and enlargement of the muscles, fatty tissue, and connective tissue within the orbit (eye socket). This leads to symptoms such as:

1. Protrusion or bulging of the eyes (exophthalmos)
2. Redness and swelling of the eyelids
3. Double vision (diplopia) due to restricted eye movement
4. Pain and discomfort, especially when looking up, down, or sideways
5. Light sensitivity (photophobia)
6. Tearing and dryness in the eyes
7. Vision loss in severe cases

The treatment for Graves' ophthalmopathy depends on the severity of the symptoms and may include medications to manage inflammation, eye drops or ointments for dryness, prisms to correct double vision, or surgery for severe cases.

Carbimazole is an antithyroid medication that is primarily used to manage hyperthyroidism, a condition characterized by an overactive thyroid gland that produces excessive amounts of thyroid hormones. The drug works by inhibiting the enzyme responsible for producing these hormones, thereby reducing their levels in the body and alleviating symptoms associated with the disorder.

Hyperthyroidism can manifest as various signs and symptoms, including rapid heartbeat, weight loss, heat intolerance, tremors, anxiety, and sleep disturbances. Common causes of hyperthyroidism include Graves' disease, toxic adenoma, and thyroiditis.

Carbimazole is a prodrug that gets converted to its active metabolite, methimazole, in the liver. Methimazole inhibits the activity of thyroperoxidase, an enzyme involved in the synthesis of thyroid hormones triiodothyronine (T3) and thyroxine (T4). By blocking this enzyme, carbimazole reduces the production of T3 and T4, ultimately helping to control hyperthyroidism.

The medication is typically administered orally in tablet form, with dosages varying depending on individual patient needs and response to treatment. Common side effects of carbimazole include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Rare but severe adverse reactions may include agranulocytosis (a severe decrease in white blood cells), aplastic anemia (a condition where the bone marrow fails to produce sufficient numbers of blood cells), and hepatotoxicity (liver damage).

Patients taking carbimazole should be closely monitored for signs of adverse reactions, and regular blood tests are necessary to assess thyroid hormone levels and potential side effects. Pregnant women should avoid using carbimazole due to the risk of birth defects in the developing fetus. In such cases, alternative antithyroid medications like propylthiouracil may be prescribed instead.

In summary, carbimazole is an antithyroid medication used primarily for managing hyperthyroidism by inhibiting thyroperoxidase and reducing the production of thyroid hormones T3 and T4. While effective, it carries potential risks and side effects that necessitate close monitoring during treatment.

Thyrotoxicosis is a medical condition that results from an excess of thyroid hormones in the body, leading to an overactive metabolic state. It can be caused by various factors such as Graves' disease, toxic adenoma, Plummer's disease, or excessive intake of thyroid hormone medication. Symptoms may include rapid heart rate, weight loss, heat intolerance, tremors, and increased sweating, among others. Thyrotoxicosis is not a diagnosis itself but a manifestation of various underlying thyroid disorders. Proper diagnosis and management are crucial to prevent complications and improve quality of life.

Hashimoto's disease, also known as chronic lymphocytic thyroiditis, is an autoimmune disorder in which the immune system mistakenly attacks and damages the thyroid gland. The resulting inflammation often leads to an underactive thyroid gland (hypothyroidism). It primarily affects middle-aged women but can also occur in men and women of any age and in children.

The exact cause of Hashimoto's disease is unclear, but it appears to involve interactions between genetic and environmental factors. The disorder tends to run in families, and having a family member with Hashimoto's disease or another autoimmune disorder increases the risk.

Symptoms of hypothyroidism include fatigue, weight gain, constipation, cold intolerance, joint and muscle pain, dry skin, thinning hair, irregular menstrual periods, and depression. However, some people with Hashimoto's disease may have no symptoms for many years.

Diagnosis is typically based on a combination of symptoms, physical examination findings, and laboratory test results. Treatment usually involves thyroid hormone replacement therapy, which can help manage symptoms and prevent complications of hypothyroidism. Regular monitoring of thyroid function is necessary to adjust the dosage of medication as needed.

Exophthalmos is a medical condition that refers to the abnormal protrusion or bulging of one or both eyes beyond the normal orbit (eye socket). This condition is also known as proptosis. Exophthalmos can be caused by various factors, including thyroid eye disease (Graves' ophthalmopathy), tumors, inflammation, trauma, or congenital abnormalities. It can lead to various symptoms such as double vision, eye discomfort, redness, and difficulty closing the eyes. Treatment of exophthalmos depends on the underlying cause and may include medications, surgery, or radiation therapy.

Subacute thyroiditis, also known as de Quervain's thyroiditis or granulomatous thyroiditis, is a inflammatory disorder of the thyroid gland. It is characterized by the presence of granulomas, which are collections of immune cells, within the thyroid tissue. The condition often follows an upper respiratory infection and is more common in women than men.

Subacute thyroiditis typically presents with pain and tenderness in the front of the neck, along with systemic symptoms such as fatigue, weakness, and low-grade fever. The disorder can cause hyperthyroidism (overactive thyroid) initially, followed by hypothyroidism (underactive thyroid) as the gland becomes damaged and inflamed. In some cases, the thyroid function may return to normal on its own after several months. Treatment typically involves anti-inflammatory medications to reduce pain and inflammation, and beta blockers to manage symptoms of hyperthyroidism.

Thyroxine (T4) is a type of hormone produced and released by the thyroid gland, a small butterfly-shaped endocrine gland located in the front of your neck. It is one of two major hormones produced by the thyroid gland, with the other being triiodothyronine (T3).

Thyroxine plays a crucial role in regulating various metabolic processes in the body, including growth, development, and energy expenditure. Specifically, T4 helps to control the rate at which your body burns calories for energy, regulates protein, fat, and carbohydrate metabolism, and influences the body's sensitivity to other hormones.

T4 is produced by combining iodine and tyrosine, an amino acid found in many foods. Once produced, T4 circulates in the bloodstream and gets converted into its active form, T3, in various tissues throughout the body. Thyroxine has a longer half-life than T3, which means it remains active in the body for a more extended period.

Abnormal levels of thyroxine can lead to various medical conditions, such as hypothyroidism (underactive thyroid) or hyperthyroidism (overactive thyroid). These conditions can cause a range of symptoms, including weight gain or loss, fatigue, mood changes, and changes in heart rate and blood pressure.

Myxedema is not a term used in modern medicine to describe a specific medical condition. However, historically, it was used to refer to the severe form of hypothyroidism, a condition characterized by an underactive thyroid gland that doesn't produce enough thyroid hormones. In hypothyroidism, various body functions slow down, which can lead to symptoms such as fatigue, weight gain, cold intolerance, constipation, and dry skin.

Myxedema specifically refers to the physical signs of severe hypothyroidism, including swelling (edema) and thickening of the skin, particularly around the face, hands, and feet, as well as a puffy appearance of the face. The term myxedema coma was used to describe a rare but life-threatening complication of long-standing, untreated hypothyroidism, characterized by altered mental status, hypothermia, and other systemic manifestations.

Nowadays, healthcare professionals use more precise medical terminology to describe these conditions, such as hypothyroidism or myxedematous edema, rather than the outdated term myxedema.

Thyroiditis is a general term that refers to inflammation of the thyroid gland. It can be caused by various factors such as infections, autoimmune disorders, or medications. Depending on the cause and severity, thyroiditis may lead to overproduction (hyperthyroidism) or underproduction (hypothyroidism) of thyroid hormones, or it can result in a temporary or permanent loss of thyroid function.

There are several types of thyroiditis, including:

1. Hashimoto's thyroiditis - an autoimmune disorder where the body attacks and damages the thyroid gland, leading to hypothyroidism.
2. Subacute granulomatous thyroiditis (De Quervain's thyroiditis) - often follows a viral infection and results in painful inflammation of the thyroid gland, causing hyperthyroidism followed by hypothyroidism.
3. Silent thyroiditis - an autoimmune disorder similar to Hashimoto's thyroiditis but without symptoms like pain or tenderness; it can cause temporary hyperthyroidism and later hypothyroidism.
4. Postpartum thyroiditis - occurs in women after childbirth, causing inflammation of the thyroid gland leading to hyperthyroidism followed by hypothyroidism.
5. Acute suppurative thyroiditis - a rare bacterial infection that causes painful swelling and redness of the thyroid gland, usually requiring antibiotics for treatment.

Symptoms of thyroiditis depend on whether it leads to hyperthyroidism or hypothyroidism. Hyperthyroidism symptoms include rapid heartbeat, weight loss, heat intolerance, anxiety, and tremors. Hypothyroidism symptoms include fatigue, weight gain, cold intolerance, constipation, dry skin, and depression. Treatment varies depending on the type of thyroiditis and its severity.

Thyrotropin, also known as thyroid-stimulating hormone (TSH), is a hormone secreted by the anterior pituitary gland. Its primary function is to regulate the production and release of thyroxine (T4) and triiodothyronine (T3) hormones from the thyroid gland. Thyrotropin binds to receptors on the surface of thyroid follicular cells, stimulating the uptake of iodide and the synthesis and release of T4 and T3. The secretion of thyrotropin is controlled by the hypothalamic-pituitary-thyroid axis: thyrotropin-releasing hormone (TRH) from the hypothalamus stimulates the release of thyrotropin, while T3 and T4 inhibit its release through a negative feedback mechanism.

Thyroid function tests (TFTs) are a group of blood tests that assess the functioning of the thyroid gland, which is a small butterfly-shaped gland located in the front of the neck. The thyroid gland produces hormones that regulate metabolism, growth, and development in the body.

TFTs typically include the following tests:

1. Thyroid-stimulating hormone (TSH) test: This test measures the level of TSH, a hormone produced by the pituitary gland that regulates the production of thyroid hormones. High levels of TSH may indicate an underactive thyroid gland (hypothyroidism), while low levels may indicate an overactive thyroid gland (hyperthyroidism).
2. Thyroxine (T4) test: This test measures the level of T4, a hormone produced by the thyroid gland. High levels of T4 may indicate hyperthyroidism, while low levels may indicate hypothyroidism.
3. Triiodothyronine (T3) test: This test measures the level of T3, another hormone produced by the thyroid gland. High levels of T3 may indicate hyperthyroidism, while low levels may indicate hypothyroidism.
4. Thyroid peroxidase antibody (TPOAb) test: This test measures the level of TPOAb, an antibody that attacks the thyroid gland and can cause hypothyroidism.
5. Thyroglobulin (Tg) test: This test measures the level of Tg, a protein produced by the thyroid gland. It is used to monitor the treatment of thyroid cancer.

These tests help diagnose and manage various thyroid disorders, including hypothyroidism, hyperthyroidism, thyroiditis, and thyroid cancer.

Autoantibodies are defined as antibodies that are produced by the immune system and target the body's own cells, tissues, or organs. These antibodies mistakenly identify certain proteins or molecules in the body as foreign invaders and attack them, leading to an autoimmune response. Autoantibodies can be found in various autoimmune diseases such as rheumatoid arthritis, lupus, and thyroiditis. The presence of autoantibodies can also be used as a diagnostic marker for certain conditions.

Hyperthyroidism is a medical condition characterized by an excessive production and release of thyroid hormones from the thyroid gland, leading to an increased metabolic rate in various body systems. The thyroid gland, located in the front of the neck, produces two main thyroid hormones: triiodothyronine (T3) and thyroxine (T4). These hormones play crucial roles in regulating many bodily functions, including heart rate, digestion, energy levels, and mood.

In hyperthyroidism, the elevated levels of T3 and T4 can cause a wide range of symptoms, such as rapid heartbeat, weight loss, heat intolerance, increased appetite, tremors, anxiety, and sleep disturbances. Some common causes of hyperthyroidism include Graves' disease, toxic adenoma, Plummer's disease (toxic multinodular goiter), and thyroiditis. Proper diagnosis and treatment are essential to manage the symptoms and prevent potential complications associated with this condition.

Thyroidectomy is a surgical procedure where all or part of the thyroid gland is removed. The thyroid gland is a butterfly-shaped endocrine gland located in the neck, responsible for producing hormones that regulate metabolism, growth, and development.

There are different types of thyroidectomy procedures, including:

1. Total thyroidectomy: Removal of the entire thyroid gland.
2. Partial (or subtotal) thyroidectomy: Removal of a portion of the thyroid gland.
3. Hemithyroidectomy: Removal of one lobe of the thyroid gland, often performed to treat benign solitary nodules or differentiated thyroid cancer.

Thyroidectomy may be recommended for various reasons, such as treating thyroid nodules, goiter, hyperthyroidism (overactive thyroid), or thyroid cancer. Potential risks and complications of the procedure include bleeding, infection, damage to nearby structures like the parathyroid glands and recurrent laryngeal nerve, and hypoparathyroidism or hypothyroidism due to removal of or damage to the parathyroid glands or thyroid gland, respectively. Close postoperative monitoring and management are essential to minimize these risks and ensure optimal patient outcomes.

Thyroid diseases are a group of conditions that affect the function and structure of the thyroid gland, a small butterfly-shaped endocrine gland located in the base of the neck. The thyroid gland produces hormones that regulate many vital functions in the body, including metabolism, growth, and development.

Thyroid diseases can be classified into two main categories: hypothyroidism and hyperthyroidism. Hypothyroidism occurs when the thyroid gland does not produce enough hormones, leading to symptoms such as fatigue, weight gain, cold intolerance, constipation, and depression. Hyperthyroidism, on the other hand, occurs when the thyroid gland produces too much hormone, resulting in symptoms such as weight loss, heat intolerance, rapid heart rate, tremors, and anxiety.

Other common thyroid diseases include:

1. Goiter: an enlargement of the thyroid gland that can be caused by iodine deficiency or autoimmune disorders.
2. Thyroid nodules: abnormal growths on the thyroid gland that can be benign or malignant.
3. Thyroid cancer: a malignant tumor of the thyroid gland that requires medical treatment.
4. Hashimoto's disease: an autoimmune disorder that causes chronic inflammation of the thyroid gland, leading to hypothyroidism.
5. Graves' disease: an autoimmune disorder that causes hyperthyroidism and can also lead to eye problems and skin changes.

Thyroid diseases are diagnosed through a combination of physical examination, medical history, blood tests, and imaging studies such as ultrasound or CT scan. Treatment options depend on the specific type and severity of the disease and may include medication, surgery, or radioactive iodine therapy.

A goiter is an abnormal enlargement of the thyroid gland, which is a butterfly-shaped endocrine gland located in the front of the neck. Goiters can be either diffuse (uniformly enlarged) or nodular (lumpy with distinct nodules). Nodular goiter refers to a thyroid gland that has developed one or more discrete lumps or nodules while the remaining tissue is normal or may also be diffusely enlarged.

Nodular goiters can be classified into two types: multinodular goiter and solitary thyroid nodule. Multinodular goiter consists of multiple nodules in the thyroid gland, while a solitary thyroid nodule is an isolated nodule within an otherwise normal or diffusely enlarged thyroid gland.

The majority of nodular goiters are benign and do not cause symptoms. However, some patients may experience signs and symptoms related to compression of nearby structures (such as difficulty swallowing or breathing), hyperthyroidism (overactive thyroid), or hypothyroidism (underactive thyroid). The evaluation of a nodular goiter typically includes a physical examination, imaging studies like ultrasound, and sometimes fine-needle aspiration biopsy to determine the nature of the nodules and assess the risk of malignancy. Treatment options depend on various factors, including the size and number of nodules, the presence of compressive symptoms, and the patient's thyroid function.

Thyroglobulin is a protein produced and used by the thyroid gland in the production of thyroid hormones, primarily thyroxine (T4) and triiodothyronine (T3). It is composed of two subunits, an alpha and a beta or gamma unit, which bind iodine atoms necessary for the synthesis of the thyroid hormones. Thyroglobulin is exclusively produced by the follicular cells of the thyroid gland.

In clinical practice, measuring thyroglobulin levels in the blood can be useful as a tumor marker for monitoring treatment and detecting recurrence of thyroid cancer, particularly in patients with differentiated thyroid cancer (papillary or follicular) who have had their thyroid gland removed. However, it is important to note that thyroglobulin is not specific to thyroid tissue and can be produced by some non-thyroidal cells under certain conditions, which may lead to false positive results in some cases.

Triiodothyronine (T3) is a thyroid hormone, specifically the active form of thyroid hormone, that plays a critical role in the regulation of metabolism, growth, and development in the human body. It is produced by the thyroid gland through the iodination and coupling of the amino acid tyrosine with three atoms of iodine. T3 is more potent than its precursor, thyroxine (T4), which has four iodine atoms, as T3 binds more strongly to thyroid hormone receptors and accelerates metabolic processes at the cellular level.

In circulation, about 80% of T3 is bound to plasma proteins, while the remaining 20% is unbound or free, allowing it to enter cells and exert its biological effects. The primary functions of T3 include increasing the rate of metabolic reactions, promoting protein synthesis, enhancing sensitivity to catecholamines (e.g., adrenaline), and supporting normal brain development during fetal growth and early infancy. Imbalances in T3 levels can lead to various medical conditions, such as hypothyroidism or hyperthyroidism, which may require clinical intervention and management.

Goiter is a medical term that refers to an enlarged thyroid gland. The thyroid gland is a small, butterfly-shaped gland located in the front of your neck below the larynx or voice box. It produces hormones that regulate your body's metabolism, growth, and development.

Goiter can vary in size and may be visible as a swelling at the base of the neck. It can be caused by several factors, including iodine deficiency, autoimmune disorders, thyroid cancer, pregnancy, or the use of certain medications. Depending on the underlying cause and the severity of the goiter, treatment options may include medication, surgery, or radioactive iodine therapy.

Iodine radioisotopes are radioactive isotopes of the element iodine, which decays and emits radiation in the form of gamma rays. Some commonly used iodine radioisotopes include I-123, I-125, I-131. These radioisotopes have various medical applications such as in diagnostic imaging, therapy for thyroid disorders, and cancer treatment.

For example, I-131 is commonly used to treat hyperthyroidism and differentiated thyroid cancer due to its ability to destroy thyroid tissue. On the other hand, I-123 is often used in nuclear medicine scans of the thyroid gland because it emits gamma rays that can be detected by a gamma camera, allowing for detailed images of the gland's structure and function.

It is important to note that handling and administering radioisotopes require specialized training and safety precautions due to their radiation-emitting properties.

Thyroid hormones are hormones produced and released by the thyroid gland, a small endocrine gland located in the neck that helps regulate metabolism, growth, and development in the human body. The two main thyroid hormones are triiodothyronine (T3) and thyroxine (T4), which contain iodine atoms. These hormones play a crucial role in various bodily functions, including heart rate, body temperature, digestion, and brain development. They help regulate the rate at which your body uses energy, affects how sensitive your body is to other hormones, and plays a vital role in the development and differentiation of all cells of the human body. Thyroid hormone levels are regulated by the hypothalamus and pituitary gland through a feedback mechanism that helps maintain proper balance.

Iodide peroxidase, also known as iodide:hydrogen peroxide oxidoreductase, is an enzyme that belongs to the family of oxidoreductases. Specifically, it is a peroxidase that uses iodide as its physiological reducing substrate. This enzyme catalyzes the oxidation of iodide by hydrogen peroxide to produce iodine, which plays a crucial role in thyroid hormone biosynthesis.

The systematic name for this enzyme is iodide:hydrogen-peroxide oxidoreductase (iodinating). It is most commonly found in the thyroid gland, where it helps to produce and regulate thyroid hormones by facilitating the iodination of tyrosine residues on thyroglobulin, a protein produced by the thyroid gland.

Iodide peroxidase requires a heme cofactor for its enzymatic activity, which is responsible for the oxidation-reduction reactions it catalyzes. The enzyme's ability to iodinate tyrosine residues on thyroglobulin is essential for the production of triiodothyronine (T3) and thyroxine (T4), two critical hormones that regulate metabolism, growth, and development in mammals.

A thyroid crisis, also known as thyrotoxic crisis or storm, is a rare but life-threatening condition characterized by an exaggerated response to the excess production of thyroid hormones (thyrotoxicosis). This condition can lead to severe hypermetabolic state, multi-organ dysfunction, and cardiovascular collapse if not promptly diagnosed and treated.

Thyroid crisis is often triggered by a stressful event, infection, or surgery in individuals with uncontrolled or poorly managed hyperthyroidism, particularly those with Graves' disease. The symptoms of thyroid crisis include high fever, tachycardia (rapid heart rate), hypertension (high blood pressure), agitation, confusion, delirium, vomiting, diarrhea, and sometimes coma.

The diagnosis of thyroid crisis is based on the clinical presentation, laboratory tests, and imaging studies. Treatment typically involves hospitalization in an intensive care unit, administration of medications to block the production and release of thyroid hormones, control heart rate and rhythm, correct electrolyte imbalances, and provide supportive care until the patient's condition stabilizes.

Hypothyroidism is a medical condition where the thyroid gland, which is a small butterfly-shaped gland located in the front of your neck, does not produce enough thyroid hormones. This results in a slowing down of the body's metabolic processes, leading to various symptoms such as fatigue, weight gain, constipation, cold intolerance, dry skin, hair loss, muscle weakness, and depression.

The two main thyroid hormones produced by the thyroid gland are triiodothyronine (T3) and thyroxine (T4). These hormones play crucial roles in regulating various bodily functions, including heart rate, body temperature, and energy levels. In hypothyroidism, the production of these hormones is insufficient, leading to a range of symptoms that can affect multiple organ systems.

Hypothyroidism can be caused by several factors, including autoimmune disorders (such as Hashimoto's thyroiditis), surgical removal of the thyroid gland, radiation therapy for neck cancer, certain medications, and congenital defects. Hypothyroidism is typically diagnosed through blood tests that measure levels of TSH (thyroid-stimulating hormone), T3, and T4. Treatment usually involves taking synthetic thyroid hormones to replace the missing hormones and alleviate symptoms.

In medical terms, the orbit refers to the bony cavity or socket in the skull that contains and protects the eye (eyeball) and its associated structures, including muscles, nerves, blood vessels, fat, and the lacrimal gland. The orbit is made up of several bones: the frontal bone, sphenoid bone, zygomatic bone, maxilla bone, and palatine bone. These bones form a pyramid-like shape that provides protection for the eye while also allowing for a range of movements.

A long-acting thyroid stimulator (LATS) is a type of antibody that can stimulate the thyroid gland to produce excess thyroid hormones over an extended period. These antibodies are typically present in individuals with Graves' disease, an autoimmune disorder characterized by hyperthyroidism, goiter, and sometimes eye changes (Graves' ophthalmopathy).

LATS binds to the TSH receptor on thyroid cells, mimicking the action of thyroid-stimulating hormone (TSH) and leading to increased production and release of thyroxine (T4) and triiodothyronine (T3), resulting in hyperthyroidism. The "long-acting" nature of these antibodies distinguishes them from other TSH receptor antibodies, which may have a more transient effect on thyroid function.

Thyroid neoplasms refer to abnormal growths or tumors in the thyroid gland, which can be benign (non-cancerous) or malignant (cancerous). These growths can vary in size and may cause a noticeable lump or nodule in the neck. Thyroid neoplasms can also affect the function of the thyroid gland, leading to hormonal imbalances and related symptoms. The exact causes of thyroid neoplasms are not fully understood, but risk factors include radiation exposure, family history, and certain genetic conditions. It is important to note that most thyroid nodules are benign, but a proper medical evaluation is necessary to determine the nature of the growth and develop an appropriate treatment plan.

Iodine is an essential trace element that is necessary for the production of thyroid hormones in the body. These hormones play crucial roles in various bodily functions, including growth and development, metabolism, and brain development during pregnancy and infancy. Iodine can be found in various foods such as seaweed, dairy products, and iodized salt. In a medical context, iodine is also used as an antiseptic to disinfect surfaces, wounds, and skin infections due to its ability to kill bacteria, viruses, and fungi.

Sodium Pertechnetate Tc 99m is a radioactive pharmaceutical preparation used in medical diagnostic imaging. It is a technetium-99m radiopharmaceutical, where technetium-99m is a metastable nuclear isomer of technetium-99, which emits gamma rays and has a half-life of 6 hours. Sodium Pertechnetate Tc 99m is used as a contrast agent in various diagnostic procedures, such as imaging of the thyroid, salivary glands, or the brain, to evaluate conditions like inflammation, tumors, or abnormalities in blood flow. It is typically administered intravenously, and its short half-life ensures that the radiation exposure is limited.

Grave robbing, also known as body snatching, is not a medical term per se, but it does have historical significance in the development of medicine. It refers to the act of digging up and stealing corpses from graves for the purpose of selling them to anatomists, medical schools, or universities for dissection and study. This illegal practice was more common in the 18th and 19th centuries when the demand for cadavers for anatomical studies exceeded the limited legal supply, often obtained through the execution of criminals. Modern medicine has strict regulations regarding the use and procurement of human bodies for research and education, making grave robbing obsolete and illegal.

Autoimmune diseases are a group of disorders in which the immune system, which normally protects the body from foreign invaders like bacteria and viruses, mistakenly attacks the body's own cells and tissues. This results in inflammation and damage to various organs and tissues in the body.

In autoimmune diseases, the body produces autoantibodies that target its own proteins or cell receptors, leading to their destruction or malfunction. The exact cause of autoimmune diseases is not fully understood, but it is believed that a combination of genetic and environmental factors contribute to their development.

There are over 80 different types of autoimmune diseases, including rheumatoid arthritis, lupus, multiple sclerosis, type 1 diabetes, Hashimoto's thyroiditis, Graves' disease, psoriasis, and inflammatory bowel disease. Symptoms can vary widely depending on the specific autoimmune disease and the organs or tissues affected. Treatment typically involves managing symptoms and suppressing the immune system to prevent further damage.

Eye diseases are a range of conditions that affect the eye or visual system, causing damage to vision and, in some cases, leading to blindness. These diseases can be categorized into various types, including:

1. Refractive errors: These include myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia, which affect the way light is focused on the retina and can usually be corrected with glasses or contact lenses.
2. Cataracts: A clouding of the lens inside the eye that leads to blurry vision, glare, and decreased contrast sensitivity. Cataract surgery is the most common treatment for this condition.
3. Glaucoma: A group of diseases characterized by increased pressure in the eye, leading to damage to the optic nerve and potential blindness if left untreated. Treatment includes medications, laser therapy, or surgery.
4. Age-related macular degeneration (AMD): A progressive condition that affects the central part of the retina called the macula, causing blurry vision and, in advanced stages, loss of central vision. Treatment may include anti-VEGF injections, laser therapy, or nutritional supplements.
5. Diabetic retinopathy: A complication of diabetes that affects the blood vessels in the retina, leading to bleeding, leakage, and potential blindness if left untreated. Treatment includes laser therapy, anti-VEGF injections, or surgery.
6. Retinal detachment: A separation of the retina from its underlying tissue, which can lead to vision loss if not treated promptly with surgery.
7. Amblyopia (lazy eye): A condition where one eye does not develop normal vision, often due to a misalignment or refractive error in childhood. Treatment includes correcting the underlying problem and encouraging the use of the weaker eye through patching or other methods.
8. Strabismus (crossed eyes): A misalignment of the eyes that can lead to amblyopia if not treated promptly with surgery, glasses, or other methods.
9. Corneal diseases: Conditions that affect the transparent outer layer of the eye, such as keratoconus, Fuchs' dystrophy, and infectious keratitis, which can lead to vision loss if not treated promptly.
10. Uveitis: Inflammation of the middle layer of the eye, which can cause vision loss if not treated promptly with anti-inflammatory medications or surgery.

The oculomotor muscles are a group of extraocular muscles that control the movements of the eye. They include:

1. Superior rectus: This muscle is responsible for elevating the eye and helping with inward rotation (intorsion) when looking downwards.
2. Inferior rectus: It depresses the eye and helps with outward rotation (extorsion) when looking upwards.
3. Medial rectus: This muscle adducts, or moves, the eye towards the midline of the face.
4. Inferior oblique: The inferior oblique muscle intorts and elevates the eye.
5. Superior oblique: It extorts and depresses the eye.

These muscles work together to allow for smooth and precise movements of the eyes, enabling tasks such as tracking moving objects, reading, and maintaining visual fixation on a single point in space.

Thyroid dysgenesis is a developmental disorder that affects the thyroid gland, which is a small butterfly-shaped gland located in the front of the neck. The thyroid gland is responsible for producing hormones that regulate metabolism, growth, and development.

In thyroid dysgenesis, the thyroid gland fails to develop properly during fetal development or early childhood. This can result in a range of abnormalities, including:

* Athyreosis: Complete absence of the thyroid gland.
* Hypoplasia: Underdevelopment of the thyroid gland, resulting in a smaller than normal gland.
* Ectopy: Displacement of the thyroid gland from its normal location in the neck to elsewhere in the body, such as the chest or tongue.
* Heterotopy: Presence of thyroid tissue in abnormal locations, such as within the thymus gland or along the course of the thyroglossal duct.

Thyroid dysgenesis can lead to hypothyroidism, a condition characterized by low levels of thyroid hormones in the body. Symptoms of hypothyroidism may include fatigue, weight gain, cold intolerance, constipation, dry skin, and depression. Treatment typically involves replacement therapy with synthetic thyroid hormones.

Hypocalcemia is a medical condition characterized by an abnormally low level of calcium in the blood. Calcium is a vital mineral that plays a crucial role in various bodily functions, including muscle contraction, nerve impulse transmission, and bone formation. Normal calcium levels in the blood usually range from 8.5 to 10.2 milligrams per deciliter (mg/dL). Hypocalcemia is typically defined as a serum calcium level below 8.5 mg/dL or, when adjusted for albumin (a protein that binds to calcium), below 8.4 mg/dL (ionized calcium).

Hypocalcemia can result from several factors, such as vitamin D deficiency, hypoparathyroidism (underactive parathyroid glands), kidney dysfunction, certain medications, and severe magnesium deficiency. Symptoms of hypocalcemia may include numbness or tingling in the fingers, toes, or lips; muscle cramps or spasms; seizures; and, in severe cases, cognitive impairment or cardiac arrhythmias. Treatment typically involves correcting the underlying cause and administering calcium and vitamin D supplements to restore normal calcium levels in the blood.

"Graves disease". Graves disease has also been called exophthalmic goiter. Less commonly, it has been known as Parry disease, ... Graves disease occurs in about 0.5% of people. Graves disease data has shown that the lifetime risk for women is around 3% ... Medical eponyms are often styled nonpossessively; thus Graves disease and Graves disease are variant stylings of the same term ... though it is not the cause of the Graves disease). Hyperthyroidism in Graves disease is confirmed, as with any other cause of ...
... disease is a condition that affects the function of the thyroid. Explore symptoms, inheritance, genetics of this condition. ... medlineplus.gov/genetics/condition/graves-disease/ Graves disease. ... Graves disease affects about 1 in 200 people. The disease occurs more often in women than in men, which may be related to ... Between 25 and 50 percent of people with Graves disease have eye abnormalities, which are known as Graves ophthalmopathy. ...
Graves disease is the most common cause of hyperthyroidism in pediatric patients. It is an immune-mediated disorder that ... The incidence of Graves disease increases with age, reaching a childhood peak during adolescence. Graves disease is a very rare ... In general, thyrotoxic Graves disease is considered in this article. Onset of Graves disease in susceptible individuals has ... Graves disease is potentially life threatening. The most severe manifestation of Graves disease is thyroid storm, which carries ...
Graves, MD, circa 1830s, is an autoimmune disease characterized by hyperthyroidism due to circulating autoantibodies. ... Graves ophthalmopathy (also known as Graves orbitopathy) is shown below.. Graves disease. Varying degrees of manifestations of ... Signs and symptoms of Graves disease. Common physical findings in Graves disease, organized by anatomic region, are as follows: ... encoded search term (Graves Disease) and Graves Disease What to Read Next on Medscape ...
Rosanne Calabrese remembers the day in 2010 when she was diagnosed with Graves disease. ... "In the case of Graves disease, the attack is mediated by an antibody that stimulates the thyroid to make too much thyroid ... Symptoms of Graves disease include anxiety, irritability, rapid heart beat, weight loss, difficulty sleeping, a change in ... Graves disease is an autoimmune disorder that causes the body to attack the thyroid. ...
... disease occurs when your childs immune system develops antibodies that attach to the thyroid cells, causing them to produce ... What causes Graves disease?. Graves disease is an autoimmune disorder. While we do not know why patients develop autoimmune ... What is Graves disease?. Graves disease occurs when your childs immune system develops antibodies that attach to the thyroid ... What are the signs and symptoms of Graves disease?. Symptoms of Graves disease may be mild or severe. Some children may have ...
... is rarer in children (prevalence, 0.02%) than it is in adults (prevalence, 0.40%); the peak incidence of ... pediatric Graves disease occurs in children aged 11 to 15 years.1 There is a 5:1 female to male preponderance.1 Graves disease ... and a thyroid scintography scan showed homogeneous tracer uptake consistent with Graves disease (C). ... Infiltrative dermopathy is the least common manifestation of the disease, occurring in fewer than 5% of patients. Infiltrative ...
... disease (GD). The present study compared the long-term efficacy of antithyroid drugs (ATD), radioactive iodine (RAI), and ... i,Objective,/i,. Thyrotoxic periodic paralysis (TPP) is a potentially life-threatening complication of Graves’ ... J. Yip, B. H. Lang, and C. Lo, "Changing trend in surgical indication and management for Graves disease," The American Journal ... E. Mazza, M. Carlini, D. Flecchia et al., "Long-term follow-up of patients with hyperthyroidism due to Graves disease treated ...
... disease is an Autoimmune disease caused by an antibody that acts as an agonist on the thryotropin receptor. ... have progression of disease.. Seum selenoprotein P levels are an indicator of oxidative state are lower in Graves disease ... and slowed progression of disease in mild Graves eye disease (Marcocci C et al). ... Although Graves disease may affect anyone, it is more common among women and has an onset before the age of 40 years. ...
Graves disease. Graves disease is an autoimmune disorder that affects the thyroid gland, which produces hormones that control ... Graves disease is the most common cause of hyperthyroidism. It tends to run in families. And it affects women more often than ... Graves disease causes the thyroid gland to produce too much thyroid hormone (hyperthyroidism), which may make a persons heart ... Signs and symptoms of Graves disease include diarrhea, rapid heart rate, inability to tolerate heat, and weight loss. ...
Wendy Williams is taking a break from her talk show to focus on resting due to her Graves Disease in May 2020. ... The Wendy Williams Show is on an indefinite hiatus as Wendy Williams deals with some health issues due to her Graves disease ... Wendy first confirmed she had been diagnosed with Graves disease, an immune system disorder, back in 2018. At the time, she ... "Recently, Wendy has been dealing with symptoms from her Graves disease which is causing fatigue," a spokesperson confirmed to ...
Graves diease is an autoimmune disorder which affects hormone production in the thyroid gland. It is the most common cause of ... Risk Factors for Graves Disease. Graves Disease is an autoimmune disease. Autoimmune diseases are where the immune system ... Prognosis of Graves Disease. Graves disease is a chronic illness without a true cure. None of the management options for this ... What is Graves Disease. Graves Disease is the most common cause of hyperthyroidism or thyrotoxicosis (increased activity of ...
In Graves disease, depression, hypomania, and psychosis can occur. While the association between Graves disease and psychosis ... disease, depression, hypomania, and psychosis can occur. While the association between Graves disease and psychosis has been ... Here, we present a case report of a patient with schizophrenia comorbid with Graves disease whose psychotic symptoms were ... Here, we present a case report of a patient with schizophrenia comorbid with Graves disease whose psychotic symptoms were ...
... disease? This autoimmune disorder can seem simple on the surface, but it can cause many other issues and complications ... What is Graves disease?. According to the U.S. Dept. of Health and Human Services, Graves disease is an autoimmune disorder ... What causes Graves disease?. Right now, its not clear exactly what causes Graves disease, but the Mayo Clinic has shared ... Heres everything we know about Graves disease, what you can do if you have it, and how long you can live with Graves disease ...
Hanage, W. P. (2017). The Next Pandemic: On the Front Lines Against Humankinds Gravest Dangers. Emerging Infectious Diseases, ... The Next Pandemic: On the Front Lines Against Humankinds Gravest Dangers. Emerging Infectious Diseases. 2017;23(12):2123. doi: ... These diseases infect humans, kill humans, and are battled by humans, with all the complicated consequences that entails. ... The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. ...
Read on Celiac disease associated with Graves Disease. ... Celiac disease associated with Graves Disease. Abstract Full ... Celiac disease is known to be associated with autoimmune diseases. However the association celiac disease, Graves disease and ... Celiac disease associated with Graves Disease. Manel Jellouli1, Souhir Thraya1, Chokri Zarrouk1, Kamel Abidi1, Karima Khiari2, ... Celiac disease associated with Graves Disease 05/27/2015 00:00:00 Manel Jellouli, Souhir Thraya, Chokri Zarrouk, Kamel Abidi, ...
These findings provide evidence that TPP is a novel molecular subtype of Graves disease. The newly identified loci, along with ... Results: A total of 537 patients with TPP (mean [SD] age, 35 [11] years; 458 male) 1519 patients with Graves disease and no ... Conclusions and relevance: These findings provide evidence that TPP is a novel molecular subtype of Graves disease. The newly ... Main outcomes and measures: Loci specifically associated with TPP risk and those shared with Graves disease and prediction ...
People living with Graves disease have a lot to focus on. The disease, an autoimmune disorder that causes an overproduction of ... If you have Graves disease and suspect you might have TED or notice changes in your eyes, you should contact an eye specialist ... A related, yet separate condition that is important for people living with Graves to focus on is Thyroid Eye Disease (TED), a ... In support of Graves Disease Awareness Month, Horizon Therapeutics and patient advocacy organization, Prevent Blindness are ...
Autoimmune thyroid disease, as exemplified by Hashimotos thyroiditis (HT) and Graves disease (GD), is characterised by a ... We did not detect HLA-G expression in the thyroids of patients with Graves disease, suggesting that HLA-G does not play a ... Analysis of cytokine gene expression in Graves disease and multi-nodular goitre. J Clin Endocrinol Metab 1994;79:355-60. ... Such infiltration occurs in the thyroid of patients with Graves disease (GD) and Hashimotos thyroiditis (HT) and can ...
Enlargement of the superior rectus and superior oblique muscles causes intorsion in Graves eye disease ... Enlargement of the superior rectus and superior oblique muscles causes intorsion in Graves eye disease ... Purpose To review the prevalence of preoperative and postoperative intorsion in patients with strabismus and Graves eye ... disease (GED), and to correlate the intorsion with coexisting superior rectus (SR) and superior oblique (SO) muscle enlargement ...
Graves disease, hyperthyroidism, NutraSweet, saccharin, social awareness, sweet poison, thyroid disease, thyrotoxicosis, weight ... Aspartame Case History: Another Case Of Graves Disease. November 13, 2019. By Janet Hull PhD, CN ... Using natural medicine to cure herself from a diagnosis of Graves disease caused by aspartame, Dr. Hull began researching the ... This article is not intended to diagnose, treat, cure, or prevent any disease. Please discuss with your own, qualified health ...
... disease Introduction Mayo Clinic overview Thyroid markers BACKGROUND: T helper type 1 (Th1), Th2, and Th17 cells produce (IFN)- ... "AUTOIMMUNE DISEASE ASSOCIATED WITH IRIS Graves Disease Several different autoimmune processes have been described in patients ... home/diseases/graves.txt. · Last modified: 09.14.2022 by 127.0.0.1. © 2015, Autoimmunity Research Foundation. All Rights ... It is widely accepted that Graves disease occurring after ART initiation is a manifestation of IRIS. This occurs late in the ...
... , Click here to explore The Institute for Advanced Reconstruction blog to learn about the different conditions ... Graves Disease December 15, 2017 Graves Ophthalmopathy: Your Questions Answered. Graves ophthalmopathy, also known as Graves ... Graves Disease January 1, 2022 Graves Eye Disease: What You Need to Know. January is National Thyroid Awareness Month, a month ... Graves Disease July 23, 2014 Surgery for Graves Disease Solves Womans Eye Problems. Dr. Tushar Patel Performs Orbital ...
Graves Disease and Thyroid Foundation. P.O. Box 2793, Rancho Santa Fe, CA 92067. Toll-Free National: 1-877-643-3123. Email: ...
Disease in Jonesborough, TN. Read about Graves disease symptoms, causes, and treatment options. ... Graves Disease Treatment in Jonesborough, TN. Graves disease is an immune disorder that causes your thyroid gland to secrete ... Graves Disease Treatment. Traditional treatment options for Graves Disease include medication, radiation, ablation, or ... Graves Disease Causes. Ask most traditional healthcare providers and they will tell you that the specific autoimmune triggers ...
Graves, MD, circa 1830s, is an autoimmune disease characterized by hyperthyroidism due to circulating autoantibodies. ... encoded search term (Graves Disease) and Graves Disease What to Read Next on Medscape ... Graves Disease Differential Diagnoses. Updated: Nov 18, 2015 * Author: Sai-Ching Jim Yeung, MD, PhD, FACP; Chief Editor: Romesh ... Graves disease in Olmsted County, Minnesota, 1935 through 1967. Mayo Clin Proc. 1970 Sep. 45(9):636-44. [QxMD MEDLINE Link]. ...
Graves disease, also Graves disease, is an autoimmune disease that leads to hyperthyroidism. Graves eye disease, also called ... general disease Learn everything you want about Graves disease..., Graves disease, also Graves disease, also known as ... S disease among … They are Graves disease can be reduced or in! Graves graves disease wiki wiki non-toxic efficiently ... disease (See brochure on Graves disease).Graves disease is an autoimmune disease caused by antibodies directed against ...
For patients with Graves disease, the effects of inorganic iodine therapy appear quickly but are often considered transient.[1] ... It is reported that in some cases, long-term control of thyroid function as well as remission of Graves disease can be achieved ... In Japan, inorganic iodine is empirically administered to Graves disease patients with mild hyperthyroidism and to those with a ... Participants Subjects were 26 infants of lactating mothers with Graves disease treated with potassium iodide (KI) for ...
graves disease medicine. A group of five medical organizations has released updated recommendations for the prevention of ... with the Infectious Diseases Society of America, the Association for Professionals in Infection Control and Epidemiology, the ...
Graves Disease and Thyroid Foundation. P.O. Box 2793, Rancho Santa Fe, CA 92067. Toll-Free National: 1-877-643-3123. Email: ...
  • The signs and symptoms of Graves' disease virtually all result from the direct and indirect effects of hyperthyroidism, with main exceptions being Graves' ophthalmopathy, goiter, and pretibial myxedema (which are caused by the autoimmune processes of the disease). (wikipedia.org)
  • Graves' disease is the most common cause of thyroid overactivity (hyperthyroidism) in the United States. (medlineplus.gov)
  • Graves disease is the most common cause of hyperthyroidism in pediatric patients. (medscape.com)
  • Although Perry was first to report hyperthyroidism in English, the classic description, in 1835, by Graves became most widely accepted. (medscape.com)
  • Graves disease is an autoimmune disorder characterized by hyperthyroidism due to circulating autoantibodies. (medscape.com)
  • Although any form of hyperthyroidism could potentially lead to TPP, Graves' disease (GD) is the most common cause of TPP (GD/TPP) [ 6 ]. (hindawi.com)
  • Graves' ophthalmopathy is potentially sight threatening eye disease generally occurring in patients with hyperthyroidism or a history of hyperthyroidism due to Graves' disease . (standardofcare.com)
  • Graves' ophthalmopathy, thyroid dermopathy, and hyperthyroidism arise from a single underlying systemic process with variable expression. (standardofcare.com)
  • Graves' ophthalmopathy occasionally may precede or follow hyperthyroidism by years (Wiersing WM et al). (standardofcare.com)
  • Graves' disease causes the thyroid gland to produce too much thyroid hormone (hyperthyroidism), which may make a person's heart pound and beat irregularly and may cause nervousness, mood changes, weakness, and fatigue. (peacehealth.org)
  • Graves' Disease is the most common cause of hyperthyroidism or thyrotoxicosis (increased activity of the thyroid gland). (healthengine.com.au)
  • Graves' Disease is the most common cause of hyperthyroidism, affecting 2-5% of females at some time, with a female:male ratio of 7:1. (healthengine.com.au)
  • Graves' disease is characterized by hyperthyroidism and one or more of the following: goiter, exophthalmos (protrusion of the eyeballs), and pretibial myxoedema (swelling on the shin above the lateral bone of the ankle). (healthengine.com.au)
  • Here, we present a case report of a patient with schizophrenia comorbid with Graves' disease whose psychotic symptoms were impacted by hyperthyroidism. (frontiersin.org)
  • Graves' disease, which is more prevalent in patients with schizophrenia than in healthy individuals ( 3 ), often presents with hyperthyroidism and psychiatric symptoms such as depression, hypomania, and psychosis ( 4 ). (frontiersin.org)
  • Aside from hyperthyroidism, Graves' is also connected to thyroid eye disease in which your eyes become swollen. (greenmatters.com)
  • Graves' disease is an immune disorder that causes your thyroid gland to secrete too much thyroid hormone (hyperthyroidism). (integrative-medicine-clinics.com)
  • Graves' disease is an autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones (a serious metabolic imbalance known as hyperthyroidism and thyrotoxicosis). (superchanceltd.com)
  • Graves' disease is a thyroid disorder characterized by goiter, exophthalmos, "orange-peel" skin, and hyperthyroidism.It is caused by an antibody-mediated auto-immune reaction, but the trigger for this reaction is still unknown. (superchanceltd.com)
  • Graves' disease is a leading cause of hyperthyroidism. (superchanceltd.com)
  • In people affected by the disease, the thyroid produces a bigger quantity of hormones than normal, which is commonly known as hyperthyroidism. (superchanceltd.com)
  • Autoimmune disease leading to hyperthyroidism. (superchanceltd.com)
  • Graves' disease is the cause of about 50% to 80% of the cases of hyperthyroidism in the United States. (superchanceltd.com)
  • Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). (superchanceltd.com)
  • Graves' disease, also Graves disease, is an autoimmune disease that leads to hyperthyroidism. (superchanceltd.com)
  • Upload media Wikipedia: Instance of: disease: Subclass of: hyperthyroidism: Named after: Robert James Graves (Graves' disease) Karl Adolph von … Although a number of disorders may result in hyperthyroidism, Graves' disease is a common cause. (superchanceltd.com)
  • In Japan, inorganic iodine is empirically administered to Graves disease patients with mild hyperthyroidism and to those with a history of adverse reactions to antithyroid drugs. (medscape.com)
  • Raw Juice therapy and Smoothies for Graves' Disease and Hyperthyroidism How it works: Raw juices of fruits and vegetables contain a lot of vitamins, minerals, trace elements, enzymes and natural sugars which helps normalizing all body functions or whose who might be affected by a disease. (gravesdiseasecure.com)
  • Can Gluten Free Diet help Graves' Disease/ Hyperthyroidism? (gravesdiseasecure.com)
  • People with Graves' disease and hyperthyroidism, or overactive thyroid, usually don't have these types of problems, I mean gaining weight. (gravesdiseasecure.com)
  • What do you need to eat, if you want to heal your Hyperthyroidism or Graves' Disease and BE Healthy again? (gravesdiseasecure.com)
  • Graves' Disease Diet Plan- 8 Foods to avoid by Svetla Bankova Most of the patients suffering with thyroid problems believe that eating the right food or avoiding the wrong one will cure them from hyperthyroidism or Graves' Disease. (gravesdiseasecure.com)
  • Twenty million people worldwide suffer from Hyperthyroidism and for 80% of them it is caused by Graves' Disease. (gravesdiseasecure.com)
  • Graves' disease is an autoimmune condition that results in hyperthyroidism , or an overactive thyroid. (healthline.com)
  • Grave's disease is a condition in which the thyroid gland produces too much hormone (hyperthyroidism). (liveradiantly.com)
  • It is closely associated with Graves' disease, an autoimmune condition that leads to overactivity of the thyroid gland (hyperthyroidism). (quickmedico.com)
  • You will be asked about your medical history, including whether you have been diagnosed with or suspect you may have Graves' disease or hyperthyroidism. (quickmedico.com)
  • Graves disease (GD) is the most common cause of hyperthyroidism, accounting for more than 90% of cases in Korea. (e-jyms.org)
  • Autoimmune hyperthyroid disorder that classically comprises hyperthyroidism with a diffuse goitre, eye disease characterized by inflammation and involvement of intra-orbital structures, dermopathy to as pretibial myxoedema, and rare involvement of the nails, fingers and long bones known as acropachy. (capsulehealth.one)
  • That's just one of the many myths patients with hyperthyroidism and Graves' disease hear from endocrinologists daily. (savemythyroid.com)
  • Today I'm sharing the top five myths patients with hyperthyroidism and Graves' disease encounter, and I'm arming you with the truth as you continue on your thyroid healing journey. (savemythyroid.com)
  • Graves' disease is the most common cause of hyperthyroidism , where your body produces too much thyroid hormone. (lifegurunewshubb.com)
  • The onset of the ophthalmopathy is in aimed to investigate the prevalence and most cases concomitant with the onset severity of ophthalmopathy in Graves of hyperthyroidism, but eye disease may patients in our area (north-east of the precede or follow hyperthyroidism [ 3 ]. (who.int)
  • Graves' disease is an autoimmune disorder resulting in the excessive production of thyroid hormones and is the most common cause of hyperthyroidism in children. (iap-kpj.org)
  • Hyperthyroidism is most commonly caused by Graves disease . (medscape.com)
  • A new review summarizes the most recent evidence regarding the pathophysiology, clinical presentation, and treatment of hyperthyroidism, clinical and subclinical Graves disease, and toxic nodular disease. (medscape.com)
  • Evidence shows that RAI treatment cures hyperthyroidism for more than 90% of patients with Graves disease or autonomous thyroid nodules. (medscape.com)
  • Treatment for subclinical hyperthyroidism is recommended for patients who are at highest risk of osteoporosis and cardiovascular disease, including those older than 65 years or with persistent serum thyrotropin level less than 0.1 mIU/L. (medscape.com)
  • A small percentage of people with Graves' disease develop a skin abnormality called pretibial myxedema or Graves' dermopathy. (medlineplus.gov)
  • 1 Graves disease is characterized by a diffuse goiter, thyrotoxicosis, associated infiltrative ophthalmopathy, and sometimes infiltrative dermopathy. (contemporarypediatrics.com)
  • Infiltrative dermopathy is the least common manifestation of the disease, occurring in fewer than 5% of patients. (contemporarypediatrics.com)
  • Options for treatment of Graves dermopathy include high-dose topical corticosteroids, intralesional corticosteroids, and intravenous immunoglobulin. (contemporarypediatrics.com)
  • In addition, having Graves' can also cause a skin condition called pretibial myxedema aka Graves' dermopathy , as per the Cleveland Clinic. (greenmatters.com)
  • Rarely, people with Graves' disease develop Graves' dermopathy, a skin condition characterized by red, swollen skin, usually on the shins and tops of the feet. (superchanceltd.com)
  • These autoantibodies can also affect the eyes ( GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). (ed.ac.uk)
  • Other symptoms may include thickening of the skin on the shins, known as pretibial myxedema, and eye bulging, a condition caused by Graves' ophthalmopathy. (wikipedia.org)
  • Studies suggest that immune system abnormalities also underlie Graves' ophthalmopathy and pretibial myxedema. (medlineplus.gov)
  • Graves disease: Special features include a diffusely enlarged thyroid gland, thyroid bruits, ophthalmopathy, pretibial myxedema, and the presence of TSIs. (medscape.com)
  • Bilateral erythematous infiltrative plaques on lower extremities in 42-year-old man with Graves disease are consistent with pretibial myxedema. (capsulehealth.one)
  • Because circulating TSI can cross the placenta, infants born to women with a history of Graves disease may have transient neonatal Graves thyrotoxicosis and require treatment. (medscape.com)
  • Iodide-induced thyrotoxicosis: The special feature is a propensity to occur in patients with a history of nodular thyroid disease who have been exposed to iodine-containing contrast agents or drugs such as amiodarone. (medscape.com)
  • Participants Subjects were 26 infants of lactating mothers with Graves disease treated with potassium iodide (KI) for postpartum thyrotoxicosis. (medscape.com)
  • We therefore prospectively investigated thyroid function in infants of lactating mothers with Graves disease who were treated with inorganic iodine for thyrotoxicosis and simultaneously measured iodine concentrations in breast milk and infant urine. (medscape.com)
  • Graves' Disease and the Manifestations of Thyrotoxicosis. (capsulehealth.one)
  • Recently, Wendy has been dealing with symptoms from her Grave's disease which is causing fatigue," a spokesperson confirmed to HollywoodLife . (hollywoodlife.com)
  • Grave's Disease is a condition caused by hyperactivity of the thyroid gland. (targetwoman.com)
  • Typically Grave's disease affects women in the age group of 20 - 40 years. (targetwoman.com)
  • Symptoms of Grave's disease include enlarged thyroid gland, rapid heartbeat, nervousness, anxiety and difficulty in sleeping. (targetwoman.com)
  • A person suffering from Grave's disease experiences increased sensitivity to heat and moist skin. (targetwoman.com)
  • Other symptoms of Grave's disease are weight loss without loss of appetite, bulging eyes and enlarged thyroid gland. (targetwoman.com)
  • Patient suffering from Grave's disease may have increased sweating, hand tremors and muscular weakness. (targetwoman.com)
  • Blood levels of thyroid hormones - thyroid-stimulating hormone (TSH) and thyroxinecan help in identifying Grave's disease. (targetwoman.com)
  • Grave's Disease is a common disease affecting adults, especially women under 40 years old. (efcnola.com)
  • This is called Euthryoid Grave's disease. (efcnola.com)
  • Grave's disease is an autoimmune disease. (liveradiantly.com)
  • In Grave's disease, the immune system creates antibodies that stimulate the thyroid gland. (liveradiantly.com)
  • In this article, we will share with you some information about Grave's disease that can hopefully get you back on track to better overall health. (liveradiantly.com)
  • First, you will learn about early diagnosis and treatment and what to look for when it comes to Grave's disease. (liveradiantly.com)
  • Once you have finished reading, you will have the information you need to take control of your Grave's disease and start enjoying better health. (liveradiantly.com)
  • Although many different conditions can trigger an overactive thyroid, the most common cause is Grave's disease. (liveradiantly.com)
  • For the majority of patients, Grave's disease escalates and causes havoc in many areas of their lives. (liveradiantly.com)
  • Patients of Grave's disease may have some of the following symptoms: anxiety and irritability, unexplained weight loss, muscle weakness, slight hand tremors, rapid and irregular heartbeat, goiter (enlarged thyroid gland), excessive sweating, and changes to a woman's menstrual cycle. (liveradiantly.com)
  • A recent study has found that 30% of women who get Grave's disease have been pregnant in the twelve months before the onset of the symptoms. (liveradiantly.com)
  • Grave's disease can also result in ophthalmopathy or thyroid eye disease. (liveradiantly.com)
  • Twenty-five percent of Grave's disease patients have symptoms of this eye disease. (liveradiantly.com)
  • The goal of the treatment of Grave's disease is to control the excessive activity of the thyroid gland. (liveradiantly.com)
  • propylthiouracil (PTU) for Grave's disease during the first trimester. (gertitashkomd.com)
  • Currently, lithium is used to treat a variety of disorders including cluster headaches, alcoholism, and Grave's disease. (cdc.gov)
  • Irritated and/or bulging eyes (called proptosis) with redness or visible blood vessels on the white part of the eye, pain when moving the eyes and inability to fully open the eyelid (known as Graves' ophthalmopathy or thyroid eye disease). (chop.edu)
  • Graves' ophthalmopathy, also known as thyroid-associated ophthalmopathy or thyroid eye disease may sometimes occur in patients with euthyroid or hypothyroid chronic autoimmune thyroiditis. (standardofcare.com)
  • Graves' eye disease, also called Graves' Ophthalmopathy or Thyroid Eye disease, is a problem that usually develops in people with an overactive thyroid caused by Graves' disease (See brochure on Graves' disease).Graves' disease is an autoimmune disease caused by antibodies directed against receptors present in the thyroid cells and also on the surface of the cells behind the eyes. (superchanceltd.com)
  • While a theoretical mechanism occurs by which exposure to severe stressors and high levels of subsequent distress such as post-traumatic stress disorder could increase the risk of immune disease and cause an aggravation of the autoimmune response that leads to Graves' disease, more robust clinical data are needed for a firm conclusion. (wikipedia.org)
  • The disease occurs more often in women than in men, which may be related to hormonal factors. (medlineplus.gov)
  • Graves' disease occurs when your child's immune system develops antibodies that attach to the thyroid cells, causing them to produce too much thyroid hormone . (chop.edu)
  • the peak incidence of pediatric Graves disease occurs in children aged 11 to 15 years. (contemporarypediatrics.com)
  • Critically important Graves disease occurs in 25% of patients, however sub clinical involvement with extreme ocular muscle enlargement is seen radiographically it up to 70% of patients. (standardofcare.com)
  • The disease also occurs most often in people between the ages of 40-49 and 60-69 years old, and people who smoke are eight times more likely to develop TED. (philasun.com)
  • Such infiltration occurs in the thyroid of patients with Graves' disease (GD) and Hashimoto's thyroiditis (HT) and can eventually result in tissue destruction. (bmj.com)
  • Graves' Disease occurs more commonly in patients who have other autoimmune disorders like diabetes. (efcnola.com)
  • The eye protrusion or bulging associated with Graves' disease occurs when eye muscles swell and push the eyes forward. (quickmedico.com)
  • However, this is rare and usually occurs in the early stages of the disease. (medicalnewstoday.com)
  • Graves' disease occurs 3-4 times more often in teenage girls than in boys. (medicalnewstoday.com)
  • This is because TED most often occurs as part of Graves' disease - an autoimmune condition that causes your immune system to attack the healthy tissue of your thyroid , skin and eyes. (lifegurunewshubb.com)
  • Acute Lyme disease, except for the peculiar skin rash it produces in 60 to 80% of the patients in which it occurs, is a summer 'flu-like' illness without a cough. (cdc.gov)
  • The most characteristic symptom of early Lyme disease is the skin rash which occurs at the site of the tick bite from 5 to 40 or more days after the bite. (cdc.gov)
  • A rash which occurs immediately after a bite is due to an allergic reaction and is not Lyme disease. (cdc.gov)
  • Graves' disease affects 1 in 10,000 children in the United States and is much less common than Hashimoto's thyroiditis (autoimmune hypothyroidism ). (chop.edu)
  • Graves' Disease (and Hashimoto's thyroiditis) is sometimes associated with other autoimmune disorders, including insulin dependent diabetes mellitus, pernicious anemia, collagen diseases, and rheumatoid arthritis . (healthengine.com.au)
  • We reported that IFN-gamma and IL-4 gene polymorphisms, which are related to higher IFN-gamma and lower IL-4 production, respectively, are more frequent in patients with severe Hashimoto's disease (HD) than in those mild HD. (mpkb.org)
  • Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. (mpkb.org)
  • Diseases such as Hashimoto's thyroiditis cause a hormone imbalance, disrupting the thyroid gland's hormone production to varying degrees. (medicalnewstoday.com)
  • Graves' disease (German: Morbus Basedow), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. (wikipedia.org)
  • Some people with Graves' disease develop an enlargement of the thyroid called a goiter. (medlineplus.gov)
  • In addition to the typical symptoms of that condition, it also presents with goiter, mood disorders and a distinctive bulging of the eyes known as Graves' opthalmopathy. (superchanceltd.com)
  • If you have Graves' disease, toxic multinodular goiter, or another hyperthyroid condition, then you won't want to miss this episode. (savemythyroid.com)
  • The most severe manifestation of Graves disease is thyroid storm, which carries a mortality risk approaching 100% in untreated adults. (medscape.com)
  • Even children and adolescents with less severe manifestations of Graves disease can display long-term consequences of this disorder, including problems with schooling and chronic loss of bone mineral. (medscape.com)
  • Symptoms of Graves' disease may be mild or severe. (chop.edu)
  • It results in the remodeling of the orbit and upper face resulting in: dry eyes, increased lacrimation, local irritation, and eyelid retraction in mild cases, but can also manifest with pronounced proptosis, diplopia, and optic nerve compression, with potential vision loss in with severe disease. (standardofcare.com)
  • Approximately 3-5% of patients have severe disease with pain, inflammation, corneal ulceration or compressive optic neuropathy. (standardofcare.com)
  • But although all of these conditions are connected to Graves' disease, they don't necessarily start once a person has Graves', and they aren't dependent on how severe someone's Graves' disease is. (greenmatters.com)
  • In one study the median CD4 count before initiation of therapy in patients who developed Graves disease was 10 cells/mm, indicating severe immunodeficiency at the time of ART initiation in this population. (mpkb.org)
  • The eye problems associated with Graves' Disease are more severe in elderly male patients and in patients who smoke cigarettes. (efcnola.com)
  • Thyroid eye disease is more common in women , but is often more severe in men. (lifegurunewshubb.com)
  • In addition, severe forms of GO can lead to and thyroid disease was first recognized sight-threatening complications. (who.int)
  • There have been few studies to evaluate with Graves disease will develop GO and the prevalence and severity of GO in Iranian severe forms affect 3% to 5% of patients. (who.int)
  • Malaria symptoms range from very mild illness to severe disease and even death. (cdc.gov)
  • As the United Nations specialized agency for health and a central partner in UNMEER, WHO has been at the forefront of these efforts on an international scale, and has characterized the Ebola virus disease outbreak "the most severe, acute health emergency seen in modern times. (who.int)
  • People with Graves' disease have an increased risk of developing other autoimmune disorders, including rheumatoid arthritis , pernicious anemia, systemic lupus erythematosus , Addison disease, celiac disease , type 1 diabetes , and vitiligo . (medlineplus.gov)
  • Graves ophthalmopathy (also known as Graves orbitopathy) is shown below. (medscape.com)
  • Approximately half the patients with GD have ocular involvement, Graves' orbitopathy. (standardofcare.com)
  • Eye lid retraction, exophthalmos , extraocular muscle dysfunction, and ocular pain arethe most common manifestations of graves orbitopathy. (standardofcare.com)
  • Orbitopathy is the main extra thyroidal manifestation of Graves' disease. (minervamedica.it)
  • An accurate diagnostic assessment is required, in order to plan an adequate treatment of Graves' orbitopathy. (minervamedica.it)
  • In Graves disease, the radioactive iodine uptake is increased, and the uptake is diffusely distributed over the entire gland. (medscape.com)
  • Graves's disease and hyperthyroid management involves a number of therapies, anti thyroid drug use, radioactive iodine treatments and even surgery if necessary. (targetwoman.com)
  • If all gross disease cannot be resected, or if residual disease is not avid for radioactive iodine, radiation therapy is often employed for locally advanced disease. (medscape.com)
  • In pediatrics, the most common second autoimmune disease is celiac disease, an intolerance to gluten . (chop.edu)
  • According to the U.S. Dept. of Health and Human Services, Graves' disease is an autoimmune disorder that causes people to have an overactive thyroid gland. (greenmatters.com)
  • Graves disease is a condition that develops due to an overactive thyroid gland. (danieltresleymd.com)
  • In people with Graves' disease, the thyroid is overactive and makes more hormones than the body needs. (medlineplus.gov)
  • Between 25 and 50 percent of people with Graves' disease have eye abnormalities, which are known as Graves' ophthalmopathy. (medlineplus.gov)
  • In people with Graves' disease, the immune system creates a protein (antibody) called thyroid-stimulating immunoglobulin (TSI). (medlineplus.gov)
  • The National Institutes of Health estimate one-third of people with Graves' disease also develop an eye condition called Graves' ophthalmopathy. (healthline.com)
  • Up to 50% of people with Graves' disease will develop some degree of Graves eye disease. (quickmedico.com)
  • Some people with Graves' disease experience major stress in their life about a year before receiving a diagnosis. (medicalnewstoday.com)
  • [ 3 , 4 ] In daily clinical practice, inorganic iodine may be administered to pregnant and lactating women with Graves disease for whom adverse reactions preclude the use of antithyroid drugs. (medscape.com)
  • The treatment options for Graves' disease include antithyroid drugs, radioiodine therapy, and thyroidectomy. (capsulehealth.one)
  • For most patients with symptoms of Graves disease, first-line treatment can begin with antithyroid drugs to reduce the synthesis and secretion of excess thyroid hormone. (medscape.com)
  • The condition is named after Irish surgeon Robert Graves, who described it in 1835. (wikipedia.org)
  • Originally known as ' exophthalmic goitre ', Graves' disease owes its name to the Irish physician, Robert James Graves , who described the condition in 1835 . (capsulehealth.one)
  • Using natural medicine to cure herself from a diagnosis of Graves' disease caused by aspartame, Dr. Hull began researching the toxic causes of disease. (janethull.com)
  • They are graves disease wiki non-toxic efficiently. (superchanceltd.com)
  • the Office of Science, National Center for Environmental Health and the Agency for Toxic Substances and Disease Registry (NCEH/ATSDR) convened a scientific advisory panel to explore opportunities for conducting additional human health studies of people previously exposed to contaminated drinking water at the Camp Lejeune. (cdc.gov)
  • A family history of thyroid dysfunction is found in approximately half the patients with Graves' disease and the pathogenesis is strongly influenced by genetics. (standardofcare.com)
  • All patients with regarding the pathogenesis, pathophysio- confirmed diagnosis of Graves disease logy, and management of this disease attending the endocrine clinics of the [ 6,7 ]. (who.int)
  • The pathogenesis of infiltrative ophthalmopathy (responsible for the exophthalmos in Graves disease) is poorly understood but may result from immunoglobulins directed to the TSH receptors in the orbital fibroblasts and fat that result in release of proinflammatory cytokines, inflammation, and accumulation of glycosaminoglycans. (msdmanuals.com)
  • Life events in the pathogenesis of Graves disease. (bvsalud.org)
  • Autoimmune diseases are where the immune system attacks certain tissues of the body, and in Graves Disease that causes overactivity of the thyroid gland. (healthengine.com.au)
  • Graves disease is associated with pernicious anemia , vitiligo , diabetes mellitus type 1 , autoimmune adrenal insufficiency , systemic sclerosis , myasthenia gravis , Sjögren syndrome , rheumatoid arthritis , and systemic lupus erythematosus . (medscape.com)
  • Graves' disease is classified as an autoimmune disorder, one of a large group of conditions that occur when the immune system attacks the body's own tissues and organs. (medlineplus.gov)
  • Graves' disease is an autoimmune disorder that affects the thyroid gland, which produces hormones that control many of the body's functions. (peacehealth.org)
  • Wendy first confirmed she had been diagnosed with Graves' disease, an immune system disorder, back in 2018. (hollywoodlife.com)
  • 2018). Graves' disease. (healthline.com)
  • The exact cause of the disease is unclear, but symptoms are a result of antibodies binding to receptors on the thyroid causing over-expression of thyroid hormone. (wikipedia.org)
  • A genetic predisposition for Graves' disease is seen, with some people more prone to develop TSH receptor-activating antibodies due to a genetic cause. (wikipedia.org)
  • Since Graves' disease is an autoimmune disease that appears suddenly, often later in life, a viral or bacterial infection may trigger antibodies, which cross-react with the human TSH receptor, a phenomenon known as antigenic mimicry. (wikipedia.org)
  • However, children with Graves disease also produce immunoglobulins directed against thyroperoxidase (anti-TPO) and thyroglobulin, as well as TSH receptor-blocking antibodies, as may be found in chronic lymphocytic thyroiditis (Hashimoto thyroiditis). (medscape.com)
  • [ 2 ] Moreover, advances in cancer immunotherapy with immune checkpoint inhibitors (anti-CTLA-4, anti-PD-1, and anti-PD-L1 antibodies) have led to immune-related adverse effects, including problems affecting the thyroid glands (ie, thyroiditis [typically with a transient hyperthyroid phase followed by a permanent hypothyroid phase] and Graves disease). (medscape.com)
  • I don't even have antibodies to Graves' disease, which is supposedly unheard of," she said. (news4jax.com)
  • You could add TSI (thyroid stimulating immunoglobulins) for the Graves antibodies-some have all three. (mpkb.org)
  • This will help show if there are any blocking antibodies for Graves, which can trick the results into thinking you are hypothyroid. (mpkb.org)
  • The TSI are the stimulating antibodies and the TRab are the blocking antibodies in Graves (hyper thryoid). (mpkb.org)
  • Graves' disease is an autoimmune condition, which means that antibodies in the immune system attach to certain receptors on cells of the thyroid gland, causing it to produce excess thyroid hormone. (medicalnewstoday.com)
  • Graves' disease is an autoimmune disorder resulting in the production of thyroid-stimulating hormone (TSH) receptor stimulating antibodies that bind and activate G Protein coupled TSH receptor to cause thyroid hormonogenesis and diffuse glandular growth. (iap-kpj.org)
  • With Graves disease, additional symptoms may include a diffusely enlarged thyroid gland, stare, or exophthalmos on examination. (medscape.com)
  • WebMD states that there are two goals when seeking treatment for Graves' disease: to stop your thyroid from overproducing thyroid hormones, and to stop the higher levels of hormones from causing even more problems for you. (greenmatters.com)
  • [ 1 ] Generally, inorganic iodine is used for preparation of surgery, for treatment of thyroid storm, and after radioiodine therapy for Graves disease. (medscape.com)
  • Introduction: There is no proved superiority between surgical and non-surgical treatment for Graves' disease up to now. (archivesheadnecksurgery.com)
  • Objective: To evaluate our surgical experience in the treatment of Graves' disease. (archivesheadnecksurgery.com)
  • Thyroidectomy is optimal treatment for Graves' disease. (archivesheadnecksurgery.com)
  • 8. Genovese BM, Noureldine SI, Gleeson EM, Tufano RP, Kandil E. What is the best definitive treatment for Graves' disease? (archivesheadnecksurgery.com)
  • Early diagnosis and treatment of Graves eye disease is key to preventing long-term eye problems. (quickmedico.com)
  • TRAb titers, smoking, and RAI treatment are strongly associated with Graves ophthalmopathy (GO) [ 12 ]. (e-jyms.org)
  • In fewer than 25% of cases, Graves' disease goes away without treatment. (medicalnewstoday.com)
  • Introduction: Treatment of Graves´ disease (GD) with radioiodine increases the risk of developing Graves´ ophthalmopathy (GO), and the link between thyroid and orbital tissue may be the presence of TSH-receptors. (lu.se)
  • But TED is a rare disease and different from Graves' disease and requires different treatment. (lifegurunewshubb.com)
  • Patients who do not receive treatment can become completely well, with a possibility of recurrent problems later, or they can develop further problems involving the heart, joints or nervous system as the disease progresses. (cdc.gov)
  • The resulting overactivity of the thyroid causes many of the signs and symptoms of Graves' disease. (medlineplus.gov)
  • Symptoms of Graves' disease include anxiety, irritability, rapid heart beat, weight loss, difficulty sleeping, a change in menstrual cycles for women and erectile dysfunction in men. (news4jax.com)
  • Signs and symptoms of Graves' disease include diarrhea, rapid heart rate, inability to tolerate heat, and weight loss. (peacehealth.org)
  • Once a patient has received a diagnosis of Graves disease, they may want to work with professionals to address some of the aesthetic issues that can occur, including bulging eyes. (danieltresleymd.com)
  • Technetium 99 scan confirmed diagnosis of Graves' disease. (iap-kpj.org)
  • 2020) What are the dermatologic manifestations of Graves disease? (capsulehealth.one)
  • Those with other autoimmune diseases, such as type 1 diabetes and rheumatoid arthritis, are more likely to be affected. (wikipedia.org)
  • Other autoimmune disease such as type 1 diabetes or rheumatoid arthritis also risks triggering graves disease. (superchanceltd.com)
  • Thyrotoxic periodic paralysis (TPP) is a potentially life-threatening complication of Graves' disease (GD). (hindawi.com)
  • Graves' disease is often associated with abnormalities affecting the eyes often referred to as Graves' ophthalmopathy. (superchanceltd.com)
  • Do all patients with Graves' eye problems have abnormalities of the thyroid gland? (efcnola.com)
  • Robert James Graves, F.R.C.S. (1796 - 1853) was an eminent Irish surgeon after whom Graves' disease takes its name. (capsulehealth.one)
  • In the case of Graves' disease, the attack is mediated by an antibody that stimulates the thyroid to make too much thyroid hormone," said Dr. R. Mack Harrell, an endocrinologist with Memorial Healthcare System. (news4jax.com)
  • In Graves' disease, the immune system develops an antibody - TSI - that attaches to the thyroid cells, leading to an unregulated, increased production of thyroid hormone, both T3 and T4. (chop.edu)
  • Autoimmune disease caused by an antibody that acts as an agonist on the thryotropin receptor. (standardofcare.com)
  • Centers for Disease Control and Prevention. (cdc.gov)
  • Dr. Ali S. Khan is a former director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention and has been close to the epicenter of almost all the potential pandemic threats of the last few decades. (cdc.gov)
  • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. (cdc.gov)
  • In some patients, Graves disease represents a part of more extensive autoimmune processes leading to dysfunction of multiple organs (eg, polyglandular autoimmune syndromes ). (medscape.com)
  • AUTOIMMUNE DISEASE ASSOCIATED WITH IRIS Graves Disease Several different autoimmune processes have been described in patients initiating ART, although a clear association with IRIS has yet to be defined for many. (mpkb.org)
  • January is National Thyroid Awareness Month, a month that aims to raise awareness for thyroid diseases and disorders. (advancedreconstruction.com)
  • 9. Scerrino G, Morfino G, Paladino NC, Di Paola V, Amodio E, Gulotta G, Bonventre S. Does thyroid surgery for Graves' disease improve health-related quality of life? (archivesheadnecksurgery.com)
  • In the Pediatric Thyroid Center at Children's Hospital of Philadelphia (CHOP), clinical experts use a variety of diagnostic tests to diagnosis Graves' disease. (chop.edu)
  • The most common clinical features of Graves' ophthalomopathy are upper eyelid retraction, edema, erythema of the periorbital tissues and conjunctiva and propptosis. (standardofcare.com)
  • Once Graves eye disease is diagnosed, your ophthalmologist will assign a clinical severity score based on exam results. (quickmedico.com)
  • We are reporting this case since the clinical association of Graves' disease in GS has never been reported before and is a rare association of the syndrome. (iap-kpj.org)
  • 18,083 males and females were included health prevention tool for reducing the burden of cervical can- in the 4vHPV clinical trials, 23,952 females for 2vHPV, and cer and other HPV-related diseases worldwide. (cdc.gov)
  • Stress is a suspected trigger for Graves' disease, along with pregnancy, cigarette smoking and genetics. (news4jax.com)
  • If you do have Graves' disease and it's left untreated, the Mayo Clinic says it could lead to even more problems like issues with pregnancy, various heart conditions, brittle bones, and something called thyroid storm. (greenmatters.com)
  • There have been case reports of congenital hypothyroidism induced by excess maternal iodine ingestion during pregnancy outside the setting of Graves disease. (medscape.com)
  • Untreated or insufficiently treated Graves disease in pregnancy may pose risks to both mother and fetus. (gertitashkomd.com)
  • Purpose To review the prevalence of preoperative and postoperative intorsion in patients with strabismus and Graves' eye disease (GED), and to correlate the intorsion with coexisting superior rectus (SR) and superior oblique (SO) muscle enlargement as a possible mechanism causing intorsion in these patients. (bmj.com)
  • Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. (medscape.com)
  • It has been suggested that the non-classic HLA class I molecule HLA-G plays a role in autoimmune disease by protecting tissues from damage by infiltrating cytotoxic T cells. (bmj.com)
  • We now aim to investigate the proportion of peripheral Th1, Th2, and Th17 cells in patients with autoimmune A condition or disease thought to arise from an overactive immune response of the body against substances and tissues normally present in the body thyroid disease (AITD). (mpkb.org)
  • Autoimmune diseases are conditions in which the human immune system attacks healthy human tissues within the body. (superchanceltd.com)
  • In Graves' ophthalmopathy, the immune system attacks the tissues and muscles surrounding the eyes, resulting in inflammation that produces a bulging-eye effect. (healthline.com)
  • Graves' Eye Disease , also known as thyroid eye disease or thyroid-associated ophthalmopathy, is an inflammatory autoimmune disorder that affects the muscles and other tissues around the eyes. (quickmedico.com)
  • Thyroid eye disease, or TED, is an autoimmune disorder that causes inflammation in the eye muscles, eyelids, tear glands and fatty tissues behind the eye. (lifegurunewshubb.com)
  • Rheumatic fever, inflammatory bowel disease, and systemic lupus erythematosus have also been reported as causes of myocarditis in children 2) . (e-apem.org)
  • Many genes associated with increased risk of GD overlap with those associated with other autoimmune diseases. (standardofcare.com)
  • Graves disease is a chronic illness without a true cure. (healthengine.com.au)
  • 13 Furthermore, the expression of HLA-G has been reported in skin biopsies taken from patients with the chronic inflammatory diseases, psoriasis 14 and atopic dermatitis, 15 and in the muscle fibres of individuals with inflammatory myopathy. (bmj.com)
  • Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease. (janusinfo.se)
  • Evans M, Carrero JJ, Bellocco R, Barany P, Qureshi AR, Seeberger A, Jacobson SH, Hylander-Rössner B, Rotnitzky A, Sjölander A. Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients. (janusinfo.se)
  • however, the symptoms of chronic, untreated Lyme disease can occur at any time of the year. (cdc.gov)
  • Materials and Methods: A total of 96 patients with Graves' disease underwent thyroidectomy from 2002 to 2012. (archivesheadnecksurgery.com)
  • The efficacy of thyroidectomy for Graves' disease: a meta-analysis. (archivesheadnecksurgery.com)
  • The NCCN recommends total thyroidectomy as the initial procedure only if invasive cancer or metastatic disease is apparent at the time of surgery, or if the patient wishes to avoid a second, completion thyroidectomy should the pathologic review reveal cancer. (medscape.com)

No images available that match "graves disease"